Education
About Us
Working with TipRanks
Follow Us
Celon Pharma SA (PL:CLN)
:CLN
CLN Stock Chart & Stats
Day’s Range― - ―
52-Week Rangezł20.85 - zł32.40
Previous CloseN/A
VolumeN/A
Average Volume (3M)15.58K
Market Cap
zł1.17B
Enterprise Valuezł1.20B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)71.3
Beta0.40
Next Earnings
Nov 19, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.62
Shares Outstanding53,856,500
10 Day Avg. Volume25,141
30 Day Avg. Volume15,579
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Celon Pharma SA News
CLN FAQ
What was Celon Pharma SA’s price range in the past 12 months?
Celon Pharma SA lowest stock price was zł20.85 and its highest was zł32.40 in the past 12 months.
What is Celon Pharma SA’s market cap?
Celon Pharma SA’s market cap is zł1.17B.
When is Celon Pharma SA’s upcoming earnings report date?
Celon Pharma SA’s upcoming earnings report date is Nov 19, 2025 which is in 50 days.
How were Celon Pharma SA’s earnings last quarter?
Celon Pharma SA released its earnings results on Sep 17, 2025. The company reported -zł0.617 earnings per share for the quarter, missing the consensus estimate of N/A by -zł0.617.
Is Celon Pharma SA overvalued?
According to Wall Street analysts Celon Pharma SA’s price is currently Overvalued.
Does Celon Pharma SA pay dividends?
Celon Pharma SA does not currently pay dividends.
What is Celon Pharma SA’s EPS estimate?
Celon Pharma SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Celon Pharma SA have?
Celon Pharma SA has 53,856,500 shares outstanding.
What happened to Celon Pharma SA’s price movement after its last earnings report?
Celon Pharma SA reported an EPS of -zł0.617 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Celon Pharma SA?
Currently, no hedge funds are holding shares in PL:CLN
Company Description
Celon Pharma SA
Celon Pharma S.A., an integrated pharmaceutical company, researches, manufactures, and markets pharmaceutical products and preparations. The company operates through Generic Drug and Innovative segments. It offers drugs to treat cancers, neurological diseases, diabetes, and other metabolic disorders. The company was founded in 2002 and is based in Lomianki, Poland. Celon Pharma S.A. is a subsidiary of Glatton Sp. z o.o.